Boston Scientific (BSX) ended the recent trading session at $71.20, demonstrating a +2.02% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.25%. On the ...

Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.

Boston Scientific announced FDA clearance for the “Any Day Dosing” feature on the company’s TheraSphere 360 ytt ...

Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX saw its stock trading at ...

Expanding its portfolio further into cardiovascular health, Marlborough medical device manufacturer Boston Scientific has entered into a definitive agreement to acquire Cortex, a California medical ...

With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.

SHANGHAI, CHINA - NOVEMBER 06: Orbera gastric balloon system, a nonsurgical treatment for obesity, is on display at Boston Scientific booth during the 6th China International Import Expo (CIIE) at the ...

Boston Scientific has plans to acquire medtech company Nalu Medical, which specializes in developing and commercializing minimally invasive chronic pain solutions. Boston Scientific has been a Nalu ...

The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted Accolade pacemakers, which may need to be replaced earlier ...

Boston Scientific Corp. artificially inflated its stock price by touting growth in key product segments that it knew was ...

Boston Scientific kicked off one of the most important healthcare conferences of the year (J.P. Morgan) with a $3.7 billion deal to bolster its urology portfolio. The Marlborough, MA-based company has ...